NCT05370404

Brief Summary

This is a research project in which two standard of care practices will be evaluated to examine the difference in outcomes. The goal is to improve patient care and safety. One group will receive prescriptions for acetaminophen, nonsteroidal anti-inflammatory drugs (NSAIDs), and magnesium. The other group will receive the recommendation to take acetaminophen, NSAIDs, and magnesium as over-the-counter drugs in the same dosage as the prescription group. The same doses and routes for non-opioid medications will be used in both groups.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
250

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 6, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 11, 2022

Completed
5 months until next milestone

Study Start

First participant enrolled

September 30, 2022

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 29, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 29, 2024

Completed
Last Updated

December 11, 2024

Status Verified

December 1, 2024

Enrollment Period

2.2 years

First QC Date

May 6, 2022

Last Update Submit

December 6, 2024

Conditions

Keywords

Medications after surgerySurveysAcetaminophenNSAIDSOpioidsElective outpatient surgeryMagnesium

Outcome Measures

Primary Outcomes (5)

  • Maximal consumption of acetaminophen and NSAIDs within 3 days after discharge from surgery

    Patient report of the number of doses within the first 3 days of the use of both acetaminophen and NSAID at home after discharge from surgery. Patients are anticipated to take up to 4 doses of acetaminophen and NSAIDs per day. Over 3 days, patients would be anticipated to take a maximum of 12 doses. This outcome is a count that ranges from 0 (no doses of acetaminophen plus NSAIDs) to 12.

    3 days following surgery discharge

  • Patient use of acetaminophen within 3 days after discharge from surgery

    Patient-reported use of acetaminophen at any point in time within the first 3 days at home after discharge from surgery.

    3 days following surgery discharge

  • Patient use of NSAIDS within 3 days after discharge from surgery

    Patient-reported use of NSAIDs at any point in time within the first 3 days at home after discharge from surgery.

    3 days following surgery discharge

  • Patient use of acetaminophen and NSAID with opioid within 3 days after discharge from surgery

    Patient-reported use of both acetaminophen and NSAID on every day oral pain medication is taken within the first 3 days at home after discharge from surgery.

    3 days following surgery discharge

  • Delayed acetaminophen and NSAID use as reported at 12-16 days after discharge from surgery

    Patient-reported use of acetaminophen and/or NSAIDs in the second week after discharge from surgery.

    12-16 days following surgery discharge

Secondary Outcomes (8)

  • Patient-reported consumption of opioid pills within 3 days after discharge from surgery

    3 days following surgery discharge

  • Patient-reported consumption of opioid pills as reported at 12-16 days after discharge from surgery

    12-16 days following surgery discharge

  • Pain intensity at site of surgery 3 days following surgery discharge

    3 days following surgery discharge

  • Pain intensity at site of surgery as reported at 12-16 days following surgery discharge

    3 days following surgery discharge

  • Medication side effects within 3 days following surgery discharge

    3 days following surgery discharge

  • +3 more secondary outcomes

Other Outcomes (1)

  • Opioid disposal

    3-16 days following surgery discharge

Study Arms (2)

Prescription Group for acetaminophen, NSAIDs, and magnesium

ACTIVE COMPARATOR

Participants will receive prescriptions from the surgical team for non-opioid pain medications to take at home after discharge from surgery. The non-opioid pain medications will be acetaminophen 1000 milligram (mg) four times a day (qid) for 3 days then as needed (prn) pain, ibuprofen 600 mg qid for 3 days then prn, and magnesium oxide 400 mg daily prn pain.

Other: Prescription by surgical team

Over the Counter Group

ACTIVE COMPARATOR

Participants will receive a recommendation from the surgical team to take over-the-counter non-opioid pain medications at home after discharge from surgery. The non-opioid pain medications will be acetaminophen 1000 mg qid for 3 days then prn pain, ibuprofen 600 mg qid for 3 days then prn, and magnesium oxide 400 mg daily prn pain.

Other: Recommendation by surgical team

Interventions

The surgical team prescribes medications to the patient

Prescription Group for acetaminophen, NSAIDs, and magnesium

The surgical team recommends the patient to take over-the-counter medications

Over the Counter Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Anticipated to be prescribed and use an opioid medication to treat acute pain after elective outpatient surgery

You may not qualify if:

  • Contraindications to taking acetaminophen or NSAIDs
  • Significant analgesic medication use before surgery
  • Inability to receive emails or phone calls for follow up assessment
  • Patients who have reoperation, another surgery, or experience complications within 14 days after surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Michigan

Ann Arbor, Michigan, 48109, United States

Location

MeSH Terms

Conditions

Acute Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Mark Bicket, MD

    University of Michigan

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

May 6, 2022

First Posted

May 11, 2022

Study Start

September 30, 2022

Primary Completion

November 29, 2024

Study Completion

November 29, 2024

Last Updated

December 11, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations